Literature DB >> 11944702

Primary dengue infection: what are the clinical distinctions from secondary infection?

C Pancharoen1, J Mekmullica, U Thisyakorn.   

Abstract

To determine the magnitude of the problem posed by primary dengue infection in children and the distinctive clinical clues that may differ from those with secondary infection, 996 children serologically diagnosed with dengue infection and admitted to the Department of Pediatrics, Chulalongkorn Hospital, Bangkok, Thailand between 1988 and 1995 were retrospectively reviewed. One hundred and thirty-nine cases (14.0%) were serologically proved to be primary dengue infection. Of these, 72 were males and 67 were females, with a mean age of 4.8 years. Common manifestations by order of frequency included fever (97.8%), hepatomegaly (71.9%), vomiting (59.0%), decreased appetite (55.4%), coryza (52.5%), drowsiness (39.6%), diarrhea (34.5%), rash (33.8%), abdominal pain (23.0%) and seizure (15.8%). The mean duration of fever before admission was 4.6 days. Common sites of bleeding were skin (41.7%), mucous membrane (14.4%) and the gastrointestinal tract (12.2%). Clinical diagnosis was categorized into dengue fever (22.3%), dengue hemorrhagic fever (60.4%) and dengue shock syndrome (17.3%). Three patients (2.2%) died. Compared with the children with secondary dengue infection (n=139), children with primary dengue infections tended to be younger, presented more commonly with coryza, diarrhea, rash and seizure; and less commonly with vomiting, headache and abdominal pain (p < 0.05). The maximal hematocrit level, the mean difference between maximal and minimal hematocrit values and the maximal percentage of neutrophils were significantly lower in the study group, whereas the maximal percentage of lymphocytes was significantly higher. Dengue fever was more common and dengue shock syndrome was less common in the study group (p < 0.05). This study has emphasized that primary dengue infection is not uncommon and is less severe than secondary infection. Clinical presentations and laboratory findings are somewhat different between the two conditions.

Entities:  

Mesh:

Year:  2001        PMID: 11944702

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  16 in total

Review 1.  Neurologic aspects of infections in international travelers.

Authors:  May H Han; Joseph R Zunt
Journal:  Neurologist       Date:  2005-01       Impact factor: 1.398

2.  Bridging Efficacy of a Tetravalent Dengue Vaccine from Children/Adolescents to Adults in Highly Endemic Countries Based on Neutralizing Antibody Response.

Authors:  Peter B Gilbert; Ying Huang; Michal Juraska; Zoe Moodie; Youyi Fong; Alexander Luedtke; Yingying Zhuang; Jason Shao; Lindsay N Carpp; Nicholas Jackson; Laurent Chambonneau; Alain Bouckenooghe; Betzana Zambrano; Carina Frago; Sophie Pallardy; Fernando Noriega
Journal:  Am J Trop Med Hyg       Date:  2019-07       Impact factor: 2.345

3.  NEUROLOGICAL INFECTIONS IN THE RETURNING INTERNATIONAL TRAVELER.

Authors:  May H Han; Melanie Walker; Joseph R Zunt
Journal:  Continuum (Minneap Minn)       Date:  2006-04

4.  Dengue viral infections.

Authors:  Padmalal Gurugama; Pankaj Garg; Jennifer Perera; Ananda Wijewickrama; Suranjith L Seneviratne
Journal:  Indian J Dermatol       Date:  2010       Impact factor: 1.494

Review 5.  Dengue viral infections.

Authors:  G N Malavige; S Fernando; D J Fernando; S L Seneviratne
Journal:  Postgrad Med J       Date:  2004-10       Impact factor: 2.401

6.  Is zinc concentration in toxic phase plasma related to dengue severity and level of transaminases?

Authors:  Kamolwish Laoprasopwattana; Chonthicha Tangcheewawatthanakul; Wanutsanun Tunyapanit; Rassamee Sangthong
Journal:  PLoS Negl Trop Dis       Date:  2013-06-20

7.  Severe neutropenia in dengue patients: prevalence and significance.

Authors:  Tun-Linn Thein; David C Lye; Yee-Sin Leo; Joshua G X Wong; Ying Hao; Annelies Wilder-Smith
Journal:  Am J Trop Med Hyg       Date:  2014-04-14       Impact factor: 2.345

8.  A hematopoietic contribution to microhemorrhage formation during antiviral CD8 T cell-initiated blood-brain barrier disruption.

Authors:  Holly L Johnson; Yi Chen; Georgette L Suidan; Jeremiah R McDole; Anne K Lohrey; Lisa M Hanson; Fang Jin; Istvan Pirko; Aaron J Johnson
Journal:  J Neuroinflammation       Date:  2012-03-27       Impact factor: 8.322

Review 9.  Is dengue a threat to the blood supply?

Authors:  D Teo; L C Ng; S Lam
Journal:  Transfus Med       Date:  2009-04       Impact factor: 2.019

10.  Clinical and laboratory features that discriminate dengue from other febrile illnesses: a diagnostic accuracy study in Rio de Janeiro, Brazil.

Authors:  Regina P Daumas; Sonia R L Passos; Raquel V C Oliveira; Rita M R Nogueira; Ingebourg Georg; Keyla B F Marzochi; Patrícia Brasil
Journal:  BMC Infect Dis       Date:  2013-02-08       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.